期刊文献+

淀粉支载氧氟沙星前药的合成及其体外释放研究 被引量:2

Synthesis and in Vitro Drug Release of Starch-Ofloxacin Conjugtion as Macromolecular Prodrug
下载PDF
导出
摘要 以淀粉和氧氟沙星为原料,合成了淀粉支载的氧氟沙星高分子前药,用核磁共振氢谱对其结构进行了结构表征、紫外分光光度计测定了氧氟沙星的接入率,并在人工胃液和人工肠液中进行了体外释放研究。结果清楚显示氧氟沙星成功接入到淀粉分子上,该高分子前药在不同介质的体外释放中均呈现零级缓慢释药,与氧氟沙星相比较,其作用时间明显增长,可以有效减缓药物成分的释放,控制血药浓度,有望大大减轻药物对胃粘膜和肠的刺激作用,并解决氧氟沙星的味苦及难溶等问题。 In order to obtain a sustained-release nicotinic acid ,starch-nicotinic acid conjugation was syn-thesized by coupling between starch and nicotinyl chloride .Its structure was characterized with FTIR and 1H-NMR.The drug-loading ratio of the product was measured by ultraviolet spectrophotometer .And in vitro drug release investigation was carried out in artificial gastric juice and artificial intestinal juice .The results clearly showed that nicotinic acid was coupled with the starch molecule successfully and the drug release rate of the conjugatation was nearly zero order without abrupt release .Compared with nicotinic acid , the effective thera-peutic time of the polymer prodrug was prolonged .So it may lead to less side-effect and relieving stimulation on gastrointestinal tract .
出处 《江西农业大学学报》 CAS CSCD 北大核心 2014年第2期413-417,共5页 Acta Agriculturae Universitatis Jiangxiensis
基金 江西省科技支撑项目(20112BBF60023 20132BAB213002) 教育部高校博士点专项基金(20113603120006) 江西省教育厅项目(GJJ12254 GJJ12252) 上海市化学生物学重点实验室开放基金项目(SKLCB-2012-02) 江西农业大学自然科学基金(QN201101)
关键词 淀粉-氧氟沙星偶联物 接入率 体外释放 前药 starch-ofloxacin conjugation drug-loading ratio in vitro release prodrug
  • 相关文献

参考文献12

  • 1杜璇,屠锡德.氧氟沙星的临床用药进展[J].江苏药学与临床研究,2005,13(5):16-19. 被引量:4
  • 2Oliphant C M, Green G M. Quinolones : a comprehensive review [ J ].American Family Physician, 2002,65 ( 3 ) :455-465.
  • 3Hayakawa I, Atarashi S, Yokohama S, et al. Synthesis and antibacterial activities of optically active ofloxacin [ J ]. Antimicrob Agents Chemother, 1986,29 ( 1 ) : 163-164.
  • 4单爱莲,吕媛,李家泰.左旋氧氟沙星和氧氟沙星的临床应用进展与评价[J].中国临床药理学杂志,1997,13(2):115-119. 被引量:105
  • 5龙琪,陈昌云,马美华,吴晓霞,方明金.β-环糊精与左氧氟沙星超分子配合物的合成、表征及其与DNA的结合性质[J].光谱实验室,2007,24(1). 被引量:8
  • 6唐建华,姜波,刘昌林,邓开峰.氧氟沙星药物的研究进展[J].中国兽药杂志,2007,41(9):29-33. 被引量:11
  • 7Sahoo S, Sahoo D, Sasmal A, et al.Synthesis of chitosan-polycaprolactone blend for control delivery of ofloxacin drug [ J ]. Car- bohydrate Polymers, 2010,79 ( 1 ) : 106-113.
  • 8Guan J, Cheng P, Huang S J, et al. Mathematic simulating of levofloxacin release from chitosan nano/microparticles [ J ]. Przeglad Elektrotechniczny, 2012,88 ( 7 ) : 345- 349.
  • 9Jay S, Dutta P K. Preparation, antibacterial and physiochemical behavior of chitosan/ofloxacin complexes [ J ]. International Journal of Polymeric Materials,2010,59 (10) :793-807.
  • 10Santosh K,Joonseok K, Dilip K T, et al.Optical study of chitosan-ofloxacin complex for biomedical applications [ J ] .Journal of Macromolecular Sciences-Pure & Applied Chemistry, 2011,48 : 789- 795.

二级参考文献78

共引文献124

同被引文献20

  • 1杜璇,屠锡德.氧氟沙星的临床用药进展[J].江苏药学与临床研究,2005,13(5):16-19. 被引量:4
  • 2万慧杰,唐星.氧氟沙星缓释胶囊家犬体内药动学及相对生物利用度[J].中国新药杂志,2006,15(17):1458-1461. 被引量:6
  • 3呼秀智,肖希龙,薛占永,陈义强.氧氟沙星缓释注射液的研制及稳定性试验[J].畜牧兽医杂志,2007,26(4):6-9. 被引量:2
  • 4陆伟根,陈亭亭.药物制剂掩味技术研究进展[J].中成药,2008,30(1):113-116. 被引量:10
  • 5Bethell D B,Day N P,Dung N M,et al.Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever[J].Antimicrob Agents Chemother,1996,40(9):2167-2172.
  • 6Mayer I,Nagy E.Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system[J].APMIS,2000,108(4):261-266.
  • 7Suzuki K,Ikari K,Imai H.Synthesis of silica nanoparticles having a well-ordered mesostructure using a double surfactant system[J].J Am Chem Soc,2004,126(2):462-463.
  • 8Slowing I I,Vivero-Escoto J L,Wu C W,et al.Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers[J].Adv Drug Deliv Rev,2008,60(11):1278-1288.
  • 9Wren A W,Cummins N M,Laffir F R,et al.The bioactivity and ion release of titanium-containing glass polyalkenoate cements for medical applications[J].J Mater Sci Mater Med,2011,22(1):19-28.
  • 10Zhao Y,Trewyn B G,Slowing I I,et al.Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP[J].J Am Chem Soc,2009,131(24):8398-8400.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部